MiR-381 regulates LRRC4, leading to upregulation of the MEK/ERK and AKT signaling and enhanced the PI3-K/AKT signaling pathway activity, in turn resulting in increased proliferation of glioma cells. This evidence concerns the gene LRRC4 and central nervous system cancer.